ArticleBreast cancer research and treatment2010

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.

Kerryn W Reding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.